** Maravai LifeSciences Holdings Inc's shares MRVI.O down
6.5% at $13 before the bell
** Biotech firm cuts its 2023 profit forecast to a range of
$0.27 to $0.33 per share from $0.32-$0.38 per share
** Co also trims its 2023 sales forecast to a range of $400
mln to $440 mln from $420 mln to $460 mln previously expected
** Q1 revenue down 68% to $79.03 mln, as demand for co's
life science services declined with a fall in COVID-19
infections
** Brokerage firms including Credit Suisse, RBC Market
Capital and Jefferies cut PTs after co reported Q1 results
** As of last close, stock had fallen ~3% YTD
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))